nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoflurane—ND1—oviduct—uterine cancer	0.0226	0.0542	CbGeAlD
Isoflurane—CALM2—semen—uterine cancer	0.0142	0.034	CbGeAlD
Isoflurane—CALM1—semen—uterine cancer	0.0141	0.0338	CbGeAlD
Isoflurane—ND1—exocrine gland—uterine cancer	0.0131	0.0313	CbGeAlD
Isoflurane—Hepatic necrosis—Progesterone—uterine cancer	0.0128	0.0464	CcSEcCtD
Isoflurane—CALM2—oviduct—uterine cancer	0.0104	0.0249	CbGeAlD
Isoflurane—Laryngospasm—Medroxyprogesterone Acetate—uterine cancer	0.00906	0.0327	CcSEcCtD
Isoflurane—Necrosis—Medroxyprogesterone Acetate—uterine cancer	0.00862	0.0311	CcSEcCtD
Isoflurane—KCNK10—renal system—uterine cancer	0.00842	0.0202	CbGeAlD
Isoflurane—KCNK3—renal system—uterine cancer	0.0076	0.0182	CbGeAlD
Isoflurane—Hepatocellular injury—Progesterone—uterine cancer	0.00746	0.027	CcSEcCtD
Isoflurane—GLRB—uterine cervix—uterine cancer	0.00704	0.0169	CbGeAlD
Isoflurane—CALM2—artery—uterine cancer	0.00689	0.0165	CbGeAlD
Isoflurane—CALM1—artery—uterine cancer	0.00686	0.0164	CbGeAlD
Isoflurane—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00676	0.0244	CcSEcCtD
Isoflurane—Necrosis—Dactinomycin—uterine cancer	0.00672	0.0243	CcSEcCtD
Isoflurane—Hyperkalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00664	0.024	CcSEcCtD
Isoflurane—Hepatic function abnormal—Progesterone—uterine cancer	0.0062	0.0224	CcSEcCtD
Isoflurane—KCNK3—female reproductive system—uterine cancer	0.00608	0.0146	CbGeAlD
Isoflurane—Hepatic failure—Progesterone—uterine cancer	0.00603	0.0218	CcSEcCtD
Isoflurane—CALM2—exocrine gland—uterine cancer	0.00601	0.0144	CbGeAlD
Isoflurane—CALM1—exocrine gland—uterine cancer	0.00598	0.0143	CbGeAlD
Isoflurane—ATP5D—myometrium—uterine cancer	0.00583	0.014	CbGeAlD
Isoflurane—ATP2C1—myometrium—uterine cancer	0.00575	0.0138	CbGeAlD
Isoflurane—KCNK2—vagina—uterine cancer	0.0057	0.0137	CbGeAlD
Isoflurane—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00562	0.0203	CcSEcCtD
Isoflurane—ND1—smooth muscle tissue—uterine cancer	0.00547	0.0131	CbGeAlD
Isoflurane—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00546	0.0197	CcSEcCtD
Isoflurane—ND1—renal system—uterine cancer	0.00527	0.0126	CbGeAlD
Isoflurane—Laryngospasm—Etoposide—uterine cancer	0.00511	0.0185	CcSEcCtD
Isoflurane—Necrosis—Etoposide—uterine cancer	0.00486	0.0176	CcSEcCtD
Isoflurane—GLRB—vagina—uterine cancer	0.00477	0.0114	CbGeAlD
Isoflurane—ATP5D—uterine cervix—uterine cancer	0.00454	0.0109	CbGeAlD
Isoflurane—ATP2C1—uterine cervix—uterine cancer	0.00448	0.0107	CbGeAlD
Isoflurane—ATP5D—smooth muscle tissue—uterine cancer	0.00441	0.0106	CbGeAlD
Isoflurane—GABRP—uterine cervix—uterine cancer	0.00439	0.0105	CbGeAlD
Isoflurane—ATP2C1—smooth muscle tissue—uterine cancer	0.00435	0.0104	CbGeAlD
Isoflurane—ATP5D—decidua—uterine cancer	0.00432	0.0104	CbGeAlD
Isoflurane—GABRE—myometrium—uterine cancer	0.00431	0.0103	CbGeAlD
Isoflurane—ATP2C1—decidua—uterine cancer	0.00427	0.0102	CbGeAlD
Isoflurane—Hepatic failure—Dactinomycin—uterine cancer	0.00426	0.0154	CcSEcCtD
Isoflurane—ATP5D—renal system—uterine cancer	0.00424	0.0102	CbGeAlD
Isoflurane—CALM3—myometrium—uterine cancer	0.00424	0.0102	CbGeAlD
Isoflurane—Hyperglycaemia—Progesterone—uterine cancer	0.00422	0.0153	CcSEcCtD
Isoflurane—ND1—female reproductive system—uterine cancer	0.00422	0.0101	CbGeAlD
Isoflurane—ATP2C1—renal system—uterine cancer	0.00419	0.01	CbGeAlD
Isoflurane—GABRP—decidua—uterine cancer	0.00418	0.01	CbGeAlD
Isoflurane—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00417	0.0151	CcSEcCtD
Isoflurane—ATP5D—endometrium—uterine cancer	0.0041	0.00983	CbGeAlD
Isoflurane—Jaundice—Progesterone—uterine cancer	0.00407	0.0147	CcSEcCtD
Isoflurane—ATP2C1—endometrium—uterine cancer	0.00405	0.0097	CbGeAlD
Isoflurane—Body temperature increased—Carboplatin—uterine cancer	0.00401	0.0145	CcSEcCtD
Isoflurane—GABRP—endometrium—uterine cancer	0.00397	0.00951	CbGeAlD
Isoflurane—ATP5D—mammalian vulva—uterine cancer	0.00397	0.00951	CbGeAlD
Isoflurane—Hepatobiliary disease—Progesterone—uterine cancer	0.00395	0.0143	CcSEcCtD
Isoflurane—ATP2C1—mammalian vulva—uterine cancer	0.00392	0.00939	CbGeAlD
Isoflurane—GABRA4—mammalian vulva—uterine cancer	0.00387	0.00927	CbGeAlD
Isoflurane—ND1—female gonad—uterine cancer	0.00384	0.00919	CbGeAlD
Isoflurane—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00383	0.0138	CcSEcCtD
Isoflurane—ATP5D—uterus—uterine cancer	0.00378	0.00906	CbGeAlD
Isoflurane—Hepatitis—Progesterone—uterine cancer	0.00375	0.0135	CcSEcCtD
Isoflurane—ATP2C1—uterus—uterine cancer	0.00373	0.00894	CbGeAlD
Isoflurane—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00369	0.0133	CcSEcCtD
Isoflurane—KCNK2—lymph node—uterine cancer	0.00369	0.00883	CbGeAlD
Isoflurane—GABRP—uterus—uterine cancer	0.00366	0.00877	CbGeAlD
Isoflurane—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.0129	CcSEcCtD
Isoflurane—Cardiac disorder—Progesterone—uterine cancer	0.00348	0.0126	CcSEcCtD
Isoflurane—ATP5D—female reproductive system—uterine cancer	0.0034	0.00815	CbGeAlD
Isoflurane—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.0034	0.0123	CcSEcCtD
Isoflurane—ATP2C1—female reproductive system—uterine cancer	0.00336	0.00804	CbGeAlD
Isoflurane—GABRE—uterine cervix—uterine cancer	0.00335	0.00803	CbGeAlD
Isoflurane—CALM2—myometrium—uterine cancer	0.00333	0.00798	CbGeAlD
Isoflurane—GABRB1—vagina—uterine cancer	0.00332	0.00796	CbGeAlD
Isoflurane—CALM1—myometrium—uterine cancer	0.00331	0.00794	CbGeAlD
Isoflurane—CALM3—uterine cervix—uterine cancer	0.0033	0.0079	CbGeAlD
Isoflurane—GABRP—female reproductive system—uterine cancer	0.00329	0.00788	CbGeAlD
Isoflurane—CALM3—smooth muscle tissue—uterine cancer	0.00321	0.00768	CbGeAlD
Isoflurane—GABRE—decidua—uterine cancer	0.00319	0.00765	CbGeAlD
Isoflurane—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00315	0.0114	CcSEcCtD
Isoflurane—CALM3—decidua—uterine cancer	0.00314	0.00753	CbGeAlD
Isoflurane—ATP5D—female gonad—uterine cancer	0.00309	0.00741	CbGeAlD
Isoflurane—GLRB—lymph node—uterine cancer	0.00309	0.00739	CbGeAlD
Isoflurane—ATP5D—vagina—uterine cancer	0.00307	0.00737	CbGeAlD
Isoflurane—ATP2C1—female gonad—uterine cancer	0.00305	0.00731	CbGeAlD
Isoflurane—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00305	0.011	CcSEcCtD
Isoflurane—ATP2C1—vagina—uterine cancer	0.00303	0.00727	CbGeAlD
Isoflurane—GABRE—endometrium—uterine cancer	0.00303	0.00726	CbGeAlD
Isoflurane—Ileus—Epirubicin—uterine cancer	0.00302	0.0109	CcSEcCtD
Isoflurane—CALM3—endometrium—uterine cancer	0.00298	0.00715	CbGeAlD
Isoflurane—GABRP—vagina—uterine cancer	0.00297	0.00713	CbGeAlD
Isoflurane—GABRE—mammalian vulva—uterine cancer	0.00293	0.00702	CbGeAlD
Isoflurane—Ventricular arrhythmia—Epirubicin—uterine cancer	0.00289	0.0104	CcSEcCtD
Isoflurane—CALM3—mammalian vulva—uterine cancer	0.00289	0.00691	CbGeAlD
Isoflurane—Cough—Progesterone—uterine cancer	0.00285	0.0103	CcSEcCtD
Isoflurane—Ileus—Doxorubicin—uterine cancer	0.0028	0.0101	CcSEcCtD
Isoflurane—CALM3—uterus—uterine cancer	0.00275	0.00659	CbGeAlD
Isoflurane—Necrosis—Epirubicin—uterine cancer	0.00273	0.00985	CcSEcCtD
Isoflurane—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.00981	CcSEcCtD
Isoflurane—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00268	0.00966	CcSEcCtD
Isoflurane—Hepatitis—Dactinomycin—uterine cancer	0.00265	0.00957	CcSEcCtD
Isoflurane—Cardiac arrest—Etoposide—uterine cancer	0.00264	0.00952	CcSEcCtD
Isoflurane—CALM2—epithelium—uterine cancer	0.00261	0.00626	CbGeAlD
Isoflurane—CALM1—epithelium—uterine cancer	0.0026	0.00623	CbGeAlD
Isoflurane—CALM2—uterine cervix—uterine cancer	0.00259	0.00621	CbGeAlD
Isoflurane—CALM1—uterine cervix—uterine cancer	0.00258	0.00618	CbGeAlD
Isoflurane—Liver injury—Epirubicin—uterine cancer	0.00254	0.00919	CcSEcCtD
Isoflurane—Necrosis—Doxorubicin—uterine cancer	0.00252	0.00911	CcSEcCtD
Isoflurane—CALM2—smooth muscle tissue—uterine cancer	0.00252	0.00603	CbGeAlD
Isoflurane—GABRE—female reproductive system—uterine cancer	0.00251	0.00602	CbGeAlD
Isoflurane—CALM1—smooth muscle tissue—uterine cancer	0.00251	0.006	CbGeAlD
Isoflurane—Delirium—Epirubicin—uterine cancer	0.00249	0.00899	CcSEcCtD
Isoflurane—Hypotension—Progesterone—uterine cancer	0.00249	0.00899	CcSEcCtD
Isoflurane—CALM2—decidua—uterine cancer	0.00247	0.00591	CbGeAlD
Isoflurane—ND1—lymph node—uterine cancer	0.00247	0.00591	CbGeAlD
Isoflurane—CALM1—decidua—uterine cancer	0.00246	0.00589	CbGeAlD
Isoflurane—CALM2—renal system—uterine cancer	0.00242	0.00581	CbGeAlD
Isoflurane—CALM1—renal system—uterine cancer	0.00241	0.00578	CbGeAlD
Isoflurane—Chills—Dactinomycin—uterine cancer	0.00238	0.00859	CcSEcCtD
Isoflurane—Bronchospasm—Etoposide—uterine cancer	0.00236	0.00851	CcSEcCtD
Isoflurane—Liver injury—Doxorubicin—uterine cancer	0.00235	0.0085	CcSEcCtD
Isoflurane—CALM2—endometrium—uterine cancer	0.00234	0.00561	CbGeAlD
Isoflurane—CALM1—endometrium—uterine cancer	0.00233	0.00559	CbGeAlD
Isoflurane—Delirium—Doxorubicin—uterine cancer	0.0023	0.00832	CcSEcCtD
Isoflurane—GABRA2—vagina—uterine cancer	0.00229	0.00549	CbGeAlD
Isoflurane—GABRE—female gonad—uterine cancer	0.00228	0.00547	CbGeAlD
Isoflurane—GABRE—vagina—uterine cancer	0.00227	0.00544	CbGeAlD
Isoflurane—CALM2—mammalian vulva—uterine cancer	0.00227	0.00543	CbGeAlD
Isoflurane—CALM1—mammalian vulva—uterine cancer	0.00226	0.0054	CbGeAlD
Isoflurane—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00814	CcSEcCtD
Isoflurane—CALM3—female gonad—uterine cancer	0.00225	0.00539	CbGeAlD
Isoflurane—CALM3—vagina—uterine cancer	0.00224	0.00536	CbGeAlD
Isoflurane—CALM2—uterus—uterine cancer	0.00216	0.00517	CbGeAlD
Isoflurane—CALM1—uterus—uterine cancer	0.00215	0.00515	CbGeAlD
Isoflurane—Hiccups—Epirubicin—uterine cancer	0.00214	0.00773	CcSEcCtD
Isoflurane—Hepatocellular injury—Epirubicin—uterine cancer	0.00214	0.00773	CcSEcCtD
Isoflurane—GABRB3—female reproductive system—uterine cancer	0.00213	0.0051	CbGeAlD
Isoflurane—Body temperature increased—Progesterone—uterine cancer	0.0021	0.0076	CcSEcCtD
Isoflurane—Hyperkalaemia—Epirubicin—uterine cancer	0.0021	0.0076	CcSEcCtD
Isoflurane—Jaundice—Etoposide—uterine cancer	0.00208	0.00752	CcSEcCtD
Isoflurane—Salivary hypersecretion—Epirubicin—uterine cancer	0.00208	0.00751	CcSEcCtD
Isoflurane—Hepatobiliary disease—Etoposide—uterine cancer	0.00202	0.0073	CcSEcCtD
Isoflurane—ATP5D—lymph node—uterine cancer	0.00199	0.00476	CbGeAlD
Isoflurane—Hiccups—Doxorubicin—uterine cancer	0.00198	0.00715	CcSEcCtD
Isoflurane—Hepatocellular injury—Doxorubicin—uterine cancer	0.00198	0.00715	CcSEcCtD
Isoflurane—ATP2C1—lymph node—uterine cancer	0.00196	0.0047	CbGeAlD
Isoflurane—Hyperkalaemia—Doxorubicin—uterine cancer	0.00195	0.00703	CcSEcCtD
Isoflurane—CALM2—female reproductive system—uterine cancer	0.00194	0.00465	CbGeAlD
Isoflurane—CALM1—female reproductive system—uterine cancer	0.00193	0.00463	CbGeAlD
Isoflurane—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00192	0.00695	CcSEcCtD
Isoflurane—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00689	CcSEcCtD
Isoflurane—CYP2B6—renal system—uterine cancer	0.0018	0.00432	CbGeAlD
Isoflurane—Cardiac disorder—Etoposide—uterine cancer	0.00178	0.00643	CcSEcCtD
Isoflurane—Hepatic function abnormal—Epirubicin—uterine cancer	0.00178	0.00642	CcSEcCtD
Isoflurane—CALM2—female gonad—uterine cancer	0.00177	0.00423	CbGeAlD
Isoflurane—CALM1—female gonad—uterine cancer	0.00176	0.00421	CbGeAlD
Isoflurane—CALM2—vagina—uterine cancer	0.00176	0.00421	CbGeAlD
Isoflurane—CALM1—vagina—uterine cancer	0.00175	0.00419	CbGeAlD
Isoflurane—Hepatic failure—Epirubicin—uterine cancer	0.00173	0.00624	CcSEcCtD
Isoflurane—Chills—Etoposide—uterine cancer	0.00172	0.00621	CcSEcCtD
Isoflurane—Vomiting—Progesterone—uterine cancer	0.00169	0.00612	CcSEcCtD
Isoflurane—CYP2E1—renal system—uterine cancer	0.00169	0.00405	CbGeAlD
Isoflurane—Rash—Progesterone—uterine cancer	0.00168	0.00606	CcSEcCtD
Isoflurane—Dermatitis—Progesterone—uterine cancer	0.00168	0.00606	CcSEcCtD
Isoflurane—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00164	0.00594	CcSEcCtD
Isoflurane—Hepatic failure—Doxorubicin—uterine cancer	0.0016	0.00578	CcSEcCtD
Isoflurane—Nausea—Progesterone—uterine cancer	0.00158	0.00571	CcSEcCtD
Isoflurane—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00554	CcSEcCtD
Isoflurane—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.0055	CcSEcCtD
Isoflurane—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00549	CcSEcCtD
Isoflurane—Body temperature increased—Dactinomycin—uterine cancer	0.00149	0.00537	CcSEcCtD
Isoflurane—GABRA2—lymph node—uterine cancer	0.00148	0.00355	CbGeAlD
Isoflurane—Cardiac arrest—Epirubicin—uterine cancer	0.00148	0.00534	CcSEcCtD
Isoflurane—GABRE—lymph node—uterine cancer	0.00147	0.00352	CbGeAlD
Isoflurane—Cough—Etoposide—uterine cancer	0.00146	0.00526	CcSEcCtD
Isoflurane—CALM3—lymph node—uterine cancer	0.00145	0.00346	CbGeAlD
Isoflurane—CYP2B6—female reproductive system—uterine cancer	0.00144	0.00346	CbGeAlD
Isoflurane—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00518	CcSEcCtD
Isoflurane—Cardiac arrest—Doxorubicin—uterine cancer	0.00137	0.00494	CcSEcCtD
Isoflurane—CYP2E1—female reproductive system—uterine cancer	0.00135	0.00324	CbGeAlD
Isoflurane—ALB—lymph node—uterine cancer	0.00134	0.00321	CbGeAlD
Isoflurane—CYP2B6—vagina—uterine cancer	0.0013	0.00313	CbGeAlD
Isoflurane—Hypotension—Etoposide—uterine cancer	0.00127	0.0046	CcSEcCtD
Isoflurane—Hyperglycaemia—Epirubicin—uterine cancer	0.00121	0.00437	CcSEcCtD
Isoflurane—Vomiting—Dactinomycin—uterine cancer	0.0012	0.00432	CcSEcCtD
Isoflurane—Rash—Dactinomycin—uterine cancer	0.00119	0.00429	CcSEcCtD
Isoflurane—Jaundice—Epirubicin—uterine cancer	0.00117	0.00422	CcSEcCtD
Isoflurane—CALM2—lymph node—uterine cancer	0.00114	0.00272	CbGeAlD
Isoflurane—Hepatobiliary disease—Epirubicin—uterine cancer	0.00113	0.00409	CcSEcCtD
Isoflurane—CALM1—lymph node—uterine cancer	0.00113	0.00271	CbGeAlD
Isoflurane—Hyperglycaemia—Doxorubicin—uterine cancer	0.00112	0.00405	CcSEcCtD
Isoflurane—Nausea—Dactinomycin—uterine cancer	0.00112	0.00404	CcSEcCtD
Isoflurane—Jaundice—Doxorubicin—uterine cancer	0.00108	0.0039	CcSEcCtD
Isoflurane—Body temperature increased—Etoposide—uterine cancer	0.00108	0.00389	CcSEcCtD
Isoflurane—Hepatitis—Epirubicin—uterine cancer	0.00107	0.00388	CcSEcCtD
Isoflurane—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00105	0.00378	CcSEcCtD
Isoflurane—Cardiac disorder—Epirubicin—uterine cancer	0.000997	0.0036	CcSEcCtD
Isoflurane—Hepatitis—Doxorubicin—uterine cancer	0.000994	0.00359	CcSEcCtD
Isoflurane—Chills—Epirubicin—uterine cancer	0.000964	0.00348	CcSEcCtD
Isoflurane—Arrhythmia—Epirubicin—uterine cancer	0.00096	0.00347	CcSEcCtD
Isoflurane—Cardiac disorder—Doxorubicin—uterine cancer	0.000923	0.00333	CcSEcCtD
Isoflurane—Chills—Doxorubicin—uterine cancer	0.000892	0.00322	CcSEcCtD
Isoflurane—Arrhythmia—Doxorubicin—uterine cancer	0.000888	0.00321	CcSEcCtD
Isoflurane—Vomiting—Etoposide—uterine cancer	0.000866	0.00313	CcSEcCtD
Isoflurane—Agitation—Epirubicin—uterine cancer	0.00086	0.00311	CcSEcCtD
Isoflurane—Rash—Etoposide—uterine cancer	0.000859	0.0031	CcSEcCtD
Isoflurane—Dermatitis—Etoposide—uterine cancer	0.000858	0.0031	CcSEcCtD
Isoflurane—Cough—Epirubicin—uterine cancer	0.000816	0.00295	CcSEcCtD
Isoflurane—Nausea—Etoposide—uterine cancer	0.000809	0.00292	CcSEcCtD
Isoflurane—Agitation—Doxorubicin—uterine cancer	0.000795	0.00287	CcSEcCtD
Isoflurane—Cough—Doxorubicin—uterine cancer	0.000755	0.00273	CcSEcCtD
Isoflurane—Hypotension—Epirubicin—uterine cancer	0.000713	0.00258	CcSEcCtD
Isoflurane—Hypotension—Doxorubicin—uterine cancer	0.00066	0.00238	CcSEcCtD
Isoflurane—Body temperature increased—Epirubicin—uterine cancer	0.000604	0.00218	CcSEcCtD
Isoflurane—Body temperature increased—Doxorubicin—uterine cancer	0.000558	0.00202	CcSEcCtD
Isoflurane—Vomiting—Epirubicin—uterine cancer	0.000485	0.00175	CcSEcCtD
Isoflurane—Rash—Epirubicin—uterine cancer	0.000481	0.00174	CcSEcCtD
Isoflurane—Dermatitis—Epirubicin—uterine cancer	0.000481	0.00174	CcSEcCtD
Isoflurane—Nausea—Epirubicin—uterine cancer	0.000453	0.00164	CcSEcCtD
Isoflurane—Vomiting—Doxorubicin—uterine cancer	0.000449	0.00162	CcSEcCtD
Isoflurane—Rash—Doxorubicin—uterine cancer	0.000445	0.00161	CcSEcCtD
Isoflurane—Dermatitis—Doxorubicin—uterine cancer	0.000445	0.00161	CcSEcCtD
Isoflurane—Nausea—Doxorubicin—uterine cancer	0.00042	0.00152	CcSEcCtD
Isoflurane—CALM1—Innate Immune System—PTEN—uterine cancer	3.63e-05	0.000119	CbGpPWpGaD
Isoflurane—CALM3—Disease—MTHFR—uterine cancer	3.63e-05	0.000119	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—PTEN—uterine cancer	3.6e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—NRAS—uterine cancer	3.6e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—NRAS—uterine cancer	3.6e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—EP300—uterine cancer	3.58e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM2—Disease—MTHFR—uterine cancer	3.51e-05	0.000115	CbGpPWpGaD
Isoflurane—CALM1—Disease—MTHFR—uterine cancer	3.51e-05	0.000115	CbGpPWpGaD
Isoflurane—ALB—Metabolism—CYP19A1—uterine cancer	3.49e-05	0.000114	CbGpPWpGaD
Isoflurane—ALB—Metabolism—STK11—uterine cancer	3.49e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM3—Signaling by Wnt—AKT1—uterine cancer	3.49e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—PTEN—uterine cancer	3.48e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—PTEN—uterine cancer	3.48e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—EP300—uterine cancer	3.46e-05	0.000113	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—EP300—uterine cancer	3.46e-05	0.000113	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—EP300—uterine cancer	3.44e-05	0.000112	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—STK11—uterine cancer	3.38e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM1—Signaling by Wnt—AKT1—uterine cancer	3.38e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM2—Signaling by Wnt—AKT1—uterine cancer	3.38e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—CCL2—uterine cancer	3.36e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—NRAS—uterine cancer	3.35e-05	0.000109	CbGpPWpGaD
Isoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.28e-05	0.000107	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—STK11—uterine cancer	3.27e-05	0.000107	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—STK11—uterine cancer	3.27e-05	0.000107	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—VEGFA—uterine cancer	3.25e-05	0.000106	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—CCL2—uterine cancer	3.25e-05	0.000106	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—CCL2—uterine cancer	3.25e-05	0.000106	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—NRAS—uterine cancer	3.24e-05	0.000106	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—NRAS—uterine cancer	3.24e-05	0.000106	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—NRAS—uterine cancer	3.21e-05	0.000105	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—NRAS—uterine cancer	3.21e-05	0.000105	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—KRAS—uterine cancer	3.2e-05	0.000105	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SOCS3—uterine cancer	3.16e-05	0.000103	CbGpPWpGaD
Isoflurane—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.13e-05	0.000102	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—MTHFR—uterine cancer	3.12e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—NRAS—uterine cancer	3.11e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—NRAS—uterine cancer	3.11e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—KRAS—uterine cancer	3.09e-05	0.000101	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—KRAS—uterine cancer	3.09e-05	0.000101	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SOCS3—uterine cancer	3.06e-05	0.0001	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SOCS3—uterine cancer	3.06e-05	0.0001	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—MTHFR—uterine cancer	3.06e-05	9.99e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CDH1—uterine cancer	3.04e-05	9.93e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—MTHFR—uterine cancer	3.04e-05	9.93e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CDKN2B—uterine cancer	3.03e-05	9.9e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IGF1R—uterine cancer	2.94e-05	9.62e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—PIK3CA—uterine cancer	2.94e-05	9.61e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CDH1—uterine cancer	2.94e-05	9.6e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CDH1—uterine cancer	2.94e-05	9.6e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—MTHFR—uterine cancer	2.94e-05	9.6e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—MTHFR—uterine cancer	2.94e-05	9.6e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CDKN2B—uterine cancer	2.93e-05	9.58e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CDKN2B—uterine cancer	2.93e-05	9.58e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—KRAS—uterine cancer	2.88e-05	9.42e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IGF1R—uterine cancer	2.84e-05	9.3e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IGF1R—uterine cancer	2.84e-05	9.3e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—TP53—uterine cancer	2.84e-05	9.3e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—PIK3CA—uterine cancer	2.84e-05	9.3e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—PIK3CA—uterine cancer	2.84e-05	9.3e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—KRAS—uterine cancer	2.79e-05	9.11e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—KRAS—uterine cancer	2.79e-05	9.11e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—KRAS—uterine cancer	2.77e-05	9.05e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—KRAS—uterine cancer	2.77e-05	9.04e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SMAD3—uterine cancer	2.77e-05	9.04e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—TP53—uterine cancer	2.75e-05	8.99e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—TP53—uterine cancer	2.75e-05	8.99e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—HRAS—uterine cancer	2.72e-05	8.89e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—KRAS—uterine cancer	2.68e-05	8.75e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—KRAS—uterine cancer	2.68e-05	8.75e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SMAD3—uterine cancer	2.67e-05	8.75e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SMAD3—uterine cancer	2.67e-05	8.75e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—CXCL8—uterine cancer	2.66e-05	8.69e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—PIK3CA—uterine cancer	2.65e-05	8.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—FGFR2—uterine cancer	2.64e-05	8.62e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—HRAS—uterine cancer	2.63e-05	8.6e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—HRAS—uterine cancer	2.63e-05	8.6e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—MTHFR—uterine cancer	2.63e-05	8.59e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—CXCL8—uterine cancer	2.57e-05	8.41e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—CXCL8—uterine cancer	2.57e-05	8.41e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—ERBB2—uterine cancer	2.56e-05	8.38e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—PIK3CA—uterine cancer	2.56e-05	8.37e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—PIK3CA—uterine cancer	2.56e-05	8.37e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—FGFR2—uterine cancer	2.55e-05	8.34e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—FGFR2—uterine cancer	2.55e-05	8.34e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—PIK3CA—uterine cancer	2.54e-05	8.31e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—PIK3CA—uterine cancer	2.54e-05	8.31e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—ERBB2—uterine cancer	2.48e-05	8.1e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—ERBB2—uterine cancer	2.48e-05	8.1e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—TP53—uterine cancer	2.46e-05	8.04e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—PIK3CA—uterine cancer	2.46e-05	8.04e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—PIK3CA—uterine cancer	2.46e-05	8.04e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—HRAS—uterine cancer	2.45e-05	8e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—AKT1—uterine cancer	2.4e-05	7.85e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CDKN1B—uterine cancer	2.37e-05	7.76e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—HRAS—uterine cancer	2.37e-05	7.74e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—HRAS—uterine cancer	2.37e-05	7.74e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—ERBB2—uterine cancer	2.36e-05	7.73e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—HRAS—uterine cancer	2.35e-05	7.69e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—HRAS—uterine cancer	2.35e-05	7.69e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—AKT1—uterine cancer	2.32e-05	7.59e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—AKT1—uterine cancer	2.32e-05	7.59e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.31e-05	7.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CDKN1B—uterine cancer	2.29e-05	7.5e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CDKN1B—uterine cancer	2.29e-05	7.5e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—ERBB2—uterine cancer	2.29e-05	7.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—ERBB2—uterine cancer	2.29e-05	7.48e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—HRAS—uterine cancer	2.27e-05	7.44e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—HRAS—uterine cancer	2.27e-05	7.44e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—ESR1—uterine cancer	2.26e-05	7.38e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CTNNB1—uterine cancer	2.24e-05	7.33e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—CDKN1B—uterine cancer	2.19e-05	7.16e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—PTEN—uterine cancer	2.18e-05	7.14e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—ESR1—uterine cancer	2.18e-05	7.14e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—ESR1—uterine cancer	2.18e-05	7.14e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CTNNB1—uterine cancer	2.17e-05	7.09e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CTNNB1—uterine cancer	2.17e-05	7.09e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—AKT1—uterine cancer	2.16e-05	7.07e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—NRAS—uterine cancer	2.13e-05	6.97e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CDKN1B—uterine cancer	2.12e-05	6.93e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CDKN1B—uterine cancer	2.12e-05	6.93e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—PTEN—uterine cancer	2.11e-05	6.91e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—PTEN—uterine cancer	2.11e-05	6.91e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—AKT1—uterine cancer	2.09e-05	6.84e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—AKT1—uterine cancer	2.09e-05	6.84e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—EP300—uterine cancer	2.08e-05	6.81e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—AKT1—uterine cancer	2.08e-05	6.79e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—AKT1—uterine cancer	2.08e-05	6.79e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—CTNNB1—uterine cancer	2.07e-05	6.77e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—NRAS—uterine cancer	2.06e-05	6.75e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—NRAS—uterine cancer	2.06e-05	6.75e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—PTEN—uterine cancer	2.02e-05	6.59e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—EP300—uterine cancer	2.02e-05	6.59e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—EP300—uterine cancer	2.02e-05	6.59e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—AKT1—uterine cancer	2.01e-05	6.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—AKT1—uterine cancer	2.01e-05	6.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CTNNB1—uterine cancer	2e-05	6.55e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CTNNB1—uterine cancer	2e-05	6.55e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CCL2—uterine cancer	1.99e-05	6.5e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—PTEN—uterine cancer	1.95e-05	6.38e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—PTEN—uterine cancer	1.95e-05	6.38e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—NRAS—uterine cancer	1.95e-05	6.37e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—EP300—uterine cancer	1.92e-05	6.29e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CCL2—uterine cancer	1.92e-05	6.28e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CCL2—uterine cancer	1.92e-05	6.28e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—NRAS—uterine cancer	1.89e-05	6.16e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—NRAS—uterine cancer	1.89e-05	6.16e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—EP300—uterine cancer	1.86e-05	6.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—EP300—uterine cancer	1.86e-05	6.08e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—KRAS—uterine cancer	1.84e-05	6e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—NRAS—uterine cancer	1.8e-05	5.88e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—KRAS—uterine cancer	1.78e-05	5.81e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—KRAS—uterine cancer	1.78e-05	5.81e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—NRAS—uterine cancer	1.74e-05	5.69e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—NRAS—uterine cancer	1.74e-05	5.69e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PTEN—uterine cancer	1.74e-05	5.68e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PTEN—uterine cancer	1.7e-05	5.56e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PTEN—uterine cancer	1.69e-05	5.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	1.69e-05	5.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—KRAS—uterine cancer	1.68e-05	5.48e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—ERBB2—uterine cancer	1.66e-05	5.42e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—EP300—uterine cancer	1.66e-05	5.41e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PTEN—uterine cancer	1.63e-05	5.34e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PTEN—uterine cancer	1.63e-05	5.34e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	1.63e-05	5.34e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	1.63e-05	5.34e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—KRAS—uterine cancer	1.62e-05	5.31e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—KRAS—uterine cancer	1.62e-05	5.31e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—EP300—uterine cancer	1.62e-05	5.3e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—EP300—uterine cancer	1.61e-05	5.27e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—ERBB2—uterine cancer	1.6e-05	5.24e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—ERBB2—uterine cancer	1.6e-05	5.24e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CXCL8—uterine cancer	1.57e-05	5.14e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—HRAS—uterine cancer	1.56e-05	5.1e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—EP300—uterine cancer	1.56e-05	5.1e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—EP300—uterine cancer	1.56e-05	5.1e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—KRAS—uterine cancer	1.55e-05	5.06e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—PIK3CA—uterine cancer	1.54e-05	5.04e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CDKN1B—uterine cancer	1.53e-05	5.02e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CXCL8—uterine cancer	1.52e-05	4.97e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CXCL8—uterine cancer	1.52e-05	4.97e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—HRAS—uterine cancer	1.51e-05	4.94e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—HRAS—uterine cancer	1.51e-05	4.94e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—KRAS—uterine cancer	1.5e-05	4.9e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—KRAS—uterine cancer	1.5e-05	4.9e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—PIK3CA—uterine cancer	1.49e-05	4.87e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—PIK3CA—uterine cancer	1.49e-05	4.87e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CDKN1B—uterine cancer	1.48e-05	4.85e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CDKN1B—uterine cancer	1.48e-05	4.85e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PTEN—uterine cancer	1.46e-05	4.78e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CTNNB1—uterine cancer	1.45e-05	4.74e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—HRAS—uterine cancer	1.43e-05	4.66e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—PIK3CA—uterine cancer	1.42e-05	4.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PTEN—uterine cancer	1.41e-05	4.62e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CTNNB1—uterine cancer	1.4e-05	4.58e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CTNNB1—uterine cancer	1.4e-05	4.58e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—EP300—uterine cancer	1.39e-05	4.56e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—HRAS—uterine cancer	1.38e-05	4.51e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—HRAS—uterine cancer	1.38e-05	4.51e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—AKT1—uterine cancer	1.38e-05	4.51e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—PIK3CA—uterine cancer	1.38e-05	4.5e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—PIK3CA—uterine cancer	1.38e-05	4.5e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PTEN—uterine cancer	1.37e-05	4.47e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PTEN—uterine cancer	1.37e-05	4.47e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—EP300—uterine cancer	1.35e-05	4.4e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—AKT1—uterine cancer	1.33e-05	4.36e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—AKT1—uterine cancer	1.33e-05	4.36e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—HRAS—uterine cancer	1.32e-05	4.3e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—EP300—uterine cancer	1.3e-05	4.26e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—EP300—uterine cancer	1.3e-05	4.26e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—VEGFA—uterine cancer	1.28e-05	4.17e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—HRAS—uterine cancer	1.27e-05	4.16e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—HRAS—uterine cancer	1.27e-05	4.16e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NRAS—uterine cancer	1.26e-05	4.12e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—AKT1—uterine cancer	1.26e-05	4.12e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—VEGFA—uterine cancer	1.23e-05	4.04e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—VEGFA—uterine cancer	1.23e-05	4.04e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.22e-05	4e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NRAS—uterine cancer	1.22e-05	3.99e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NRAS—uterine cancer	1.22e-05	3.99e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—AKT1—uterine cancer	1.22e-05	3.98e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—AKT1—uterine cancer	1.22e-05	3.98e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.2e-05	3.92e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PIK3CA—uterine cancer	1.19e-05	3.9e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—AKT1—uterine cancer	1.16e-05	3.8e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PIK3CA—uterine cancer	1.15e-05	3.77e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PIK3CA—uterine cancer	1.15e-05	3.77e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—AKT1—uterine cancer	1.12e-05	3.68e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—AKT1—uterine cancer	1.12e-05	3.68e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—KRAS—uterine cancer	1.08e-05	3.55e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KRAS—uterine cancer	1.05e-05	3.43e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KRAS—uterine cancer	1.05e-05	3.43e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PIK3CA—uterine cancer	1.03e-05	3.37e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—AKT1—uterine cancer	1e-05	3.27e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PIK3CA—uterine cancer	9.96e-06	3.26e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—AKT1—uterine cancer	9.8e-06	3.2e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—AKT1—uterine cancer	9.73e-06	3.18e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TP53—uterine cancer	9.64e-06	3.15e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PIK3CA—uterine cancer	9.64e-06	3.15e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PIK3CA—uterine cancer	9.64e-06	3.15e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—AKT1—uterine cancer	9.42e-06	3.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—AKT1—uterine cancer	9.42e-06	3.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TP53—uterine cancer	9.32e-06	3.05e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TP53—uterine cancer	9.32e-06	3.05e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—HRAS—uterine cancer	9.22e-06	3.01e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—HRAS—uterine cancer	8.92e-06	2.92e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—HRAS—uterine cancer	8.92e-06	2.92e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—AKT1—uterine cancer	8.42e-06	2.75e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—AKT1—uterine cancer	8.14e-06	2.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—AKT1—uterine cancer	7.87e-06	2.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—AKT1—uterine cancer	7.87e-06	2.57e-05	CbGpPWpGaD
